Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1714567

registered interest
date	29/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information her Department holds on the availability of Creon 25000 across the UK.
tabling member constituency	Glasgow East
tabling member printed	David Linden
uin	24095
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>We are aware of ongoing intermittent supply issues with Creon 25000 gastro-resistant capsules. These are due to manufacturing and active pharmaceutical ingredient constraints. The supplier has confirmed that stock of Creon 25000 gastro resistant capsules is now available, with further deliveries scheduled in May 2024. The Department has issued guidance to healthcare professionals regarding treatment of patients, while there was disruption to the supply of Creon 25000 gastro-resistant capsules. We continue to explore all management options to manage this issue. We have asked the supplier to continue confirming their future forecasts, and to inform us of any further gaps in supply of Creon 25000 gastro-resistant capsules.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with the suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols (SSPs), and issuing NHS communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 24096 question first answered 01/05/2024 16:00:34 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4640 label Biography information for David Linden

1685577

registered interest
date	29/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help increase the supply of Creon on the NHS.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	11787
answer	answer is ministerial correction date of answer 05/02/2024 answer text <p>The Department was made aware of a global supply issue with Creon 25000 gastro-resistant capsules in autumn 2023. We worked with the manufacturers to resolve that issue and stock is currently available. We are continuing to work with the manufacturers of Creon 25000 to help ensure that action is taken to resolve any further issues that may arise, as quickly as possible, to maintain continuity of supply of this important medicine for patients in the United Kingdom.</p><p>We understand how frustrating and distressing medicine supply issues can be. While we can’t always prevent supply issues from occurring, the Department has a range of well-established processes and tools to manage them when they arise and help mitigate risks to patients.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 05/02/2024 13:17:57 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4131 label Biography information for Jim Shannon

1676009

registered interest
date	06/12/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pancreatin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help secure the supply of Creon 25000 for patients ordinarily prescribed that pharmaceutical.
tabling member constituency	Great Yarmouth
tabling member printed	Sir Brandon Lewis
uin	5556
answer	answer is ministerial correction date of answer 12/12/2023 answer text <p>The Department was made aware of a short-term supply issue with Creon 25000 gastro-resistant capsules, in September and November 2023. The supplier has since confirmed that it is back in stock, and we are not aware of any further issues with supply of Creon.</p><p>The Department has well-established processes for managing and mitigating medicine supply issues, which involve working with the pharmaceutical industry, the Medicines and Healthcare products Regulatory Agency, NHS England, the devolved governments, and others operating in the supply chain to help ensure patients have access to the treatments they need.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 12/12/2023 14:34:40 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4009 label Biography information for Sir Brandon Lewis